Blood Pressure Medication Recalled Over Cancer Concerns

Another pharmaceutical company has issued a voluntary recall of its blood pressure medication.

Wednesday, November 28th 2018, 3:33 pm

By: News 9


Another pharmaceutical company has issued a voluntary recall of its blood pressure medication.

Teva Pharmaceuticals said their Amlodipine / Valsartan combination tablets and Amlodipine / Valsartan / Hydrochlorothiazide combination tablets contain valsartan which was manufactured by Mylan.

On Tuesday, Memphis CBS station WREG reported that Mylan had recalled that medicine due to the fact it contained trace amounts of  N-nitrosodiethylamine (NDEA), a probably human carcinogen.

Teva is now recalling their products as well.

The U.S. Food and Drug Administration released information on the recall.

","published":"2018-11-28T21:33:41.000Z","updated":"2018-11-28T21:33:41.000Z","summary":"Another pharmaceutical company has issued a voluntary recall of its blood pressure medication.","affiliate":{"_id":"5cc353fe1c9d440000d3b70f","callSign":"kwtv","origin":"https://www.news9.com"},"contentClass":"news","createdAt":"2020-01-31T19:43:40.164Z","updatedAt":"2025-05-29T07:06:19.701Z","__v":16,"breakingNews":[],"entities":[{"_id":"62421a746880e45323a24ceb","text":"Mylan","type":"ORGANIZATION","__v":0},{"_id":"62421a746880e45323a24cf6","text":"WREG","type":"ORGANIZATION","__v":0},{"_id":"62421a746880e45323a24d01","text":"Teva","type":"ORGANIZATION","__v":0}],"openInNewWindow":false,"hasBeenCheckedForEntities":true,"rendered":78,"peerReviewer":"5c7850eac1778925af4208da","peerReviewedOn":"2025-04-05T20:12:26.524Z","wordCount":300,"show":true,"link":"/story/5e34836c527dcf49dad770c0/blood-pressure-medication-recalled-over-cancer-concerns","hasSchedule":false,"id":"5e34836c527dcf49dad770c0"};
logo

Get The Daily Update!

Be among the first to get breaking news, weather, and general news updates from News 9 delivered right to your inbox!

More Like This

November 28th, 2018

June 19th, 2025

April 30th, 2025

April 30th, 2025

Top Headlines

July 14th, 2025

July 14th, 2025

July 13th, 2025

July 13th, 2025